Barron Associates
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Barron Associates sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Barron Associates: 10 sponsored US clinical trials, 1 recruiting.
Barron Associates sponsors 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 6 completed. The most-studied condition in this pipeline is Ocular Motility Disorders, with 1 trials.
Top-decile sponsor footprint
Barron Associates ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
Knee Biofeedback Rehabilitation Through Game Therapy
NCT06090097
Virtual Activities of Living for Occupational Rehabilitation
NCT07450586
A System to Help With Freezing of Gait in Parkinson's Patients
NCT07542743
Respiratory Oxygen Adherence Monitor for Chronic Obstructive Pulmonary Disease Patients
NCT06874101
Motivating Occupational Virtual Experiences In Therapy for Kids
NCT04510857
Intelligent and Adaptive Control Applied to Powered Walkers
NCT05465239
Glove Rehabilitation Application for Stroke Patients
NCT03872466
A New Approach to Vision Therapy Based on Naturalistic 3-D Computer Gaming
NCT03066063
Head-Mounted Vibrotactile Prosthesis for Patients With Chronic Postural Instability
NCT03330262
Virtual Occupational Therapy Application
NCT02706912
Therapeutic Areas
What is open in the Barron Associates pipeline
1 recruiting of 10 indexed (10% open); 6 completed (60%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Ocular Motility Disorders (1 trial), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Barron Associates: open-pipeline peers nationwide
Peers matched on 10 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Barron Associates sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Abiomed · 10% recruiting · 20 trials
- Aimmune Therapeutics · 10% recruiting · 10 trials
- Altria Client Services · 10% recruiting · 10 trials
- Alzheimer's Disease Cooperative Study (ADCS) · 10% recruiting · 10 trials
Related
What to do with this Barron Associates page
10 registered trials is a research-attention snapshot, not an endorsement of Barron Associates or any single study.
- 1 of Barron Associates's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Ocular Motility Disorders is the condition Barron Associates studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Ocular Motility Disorders trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Barron Associates pipeline card: 10 registered trials from official public datasets.Report a data error.